Angiotensin and the remodelling of the myocardium.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1365-2125.1989.TB03589.XPMID 2690905PMCID PMC1379855
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure.

  1989cited by this paper
• Myocardial stiffness and reparative fibrosis following coronary embolisation in the rat.

  1989cited by this paper
• Fibrosis-induced reduction of endomyocardium in the rat after isoproterenol treatment.

  1989cited by this paper
• Myocardial fibrosis in nonhuman primate with pressure overload hypertrophy.

  1989cited by this paper
• Epidemiological aspects of heart failure.

  1989cited by this paper
• Fibrillar Collagen and Myocardial Stiffness in the Intact Hypertrophied Rat Left Ventricle

  1989cited by this paper
• Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy.

  1988cited by this paper
• Microvascular Changes in the Heart During Chronic Arterial Hypertension

  1988cited by this paper
• Collagen compartment remodeling in the pressure overloaded left ventricle

  1988cited by this paper
• Structural vs. contractile protein remodeling and myocardial stiffness in hypertrophied rat left ventricle.

  1988cited by this paper
• Collagen Remodeling of the Pressure‐Overloaded, Hypertrophied Nonhuman Primate Myocardium

  1988cited by this paper
• Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy.

  1987cited by this paper
• Left Ventricular Hypertrophy and Risk of Cardiac Failure: Insights from the Framingham Study

  1987cited by this paper
• Physiologic Versus Pathologic Hypertrophy and the Pressure‐Overloaded Myocardium

  1987cited by this paper
• Myocardial hypertrophy in Macaca fascicularis. Structural remodeling of the collagen matrix.

  1987cited by this paper
• Myocyte cell loss and myocyte hypertrophy in the aging rat heart.

  1986cited by this paper
• Morphometric analysis of collagen network and plasma perfused capillary bed in the myocardium of rats during evolution of cardiac hypertrophy

  1986cited by this paper
• Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy.

  1986cited by this paper
• Effects of antihypertensive treatment in one-clip, two kidney hypertension in rats.

  1986cited by this paper
• Structural analysis of pressure versus volume overload hypertrophy of cat right ventricle.

  1985cited by this paper
• Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade.

  1984cited by this paper
• Connective tissue content and myocardial stiffness in pressure overload hypertrophy A combined study of morphologic, morphometric, biochemical, and mechanical parameters

  1983cited by this paper
• Ultrastructural correlates of reduced cardiac function in human heart disease.

  1983cited by this paper
• Muscle fiber orientation and connective tissue content in the hypertrophied human heart.

  1982cited by this paper
• Reversal of cardiac hypertrophy in renal hypertensive rats: medical vs. surgical therapy.

  1981cited by this paper
• Diastolic Function and Myocardial Structure in Patients with Myocardial Hypertrophy: Special Reference to Normalized Viscoelastic Data

  1981cited by this paper
• The Distribution of Fibrosis in the Left Ventricle in Congenital Aortic Stenosis and Coarctation of the Aorta

  1980cited by this paper
• Effect of Converting Enzyme Inhibitor (SQ14,225) on Myocardial Hypertrophy in Spontaneously Hypertensive Rats

  1980cited by this paper
• Correlations of fibrosis in endomyocardial biopsies from patients with aortic valve disease.

  1980cited by this paper
• Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis.

  1980cited by this paper
• The Cardiac Hypertrophy Process

  1979cited by this paper
• Histopathological types of cardiac fibrosis in myocardial disease

  1979cited by this paper
• Collagen synthesis in development and reversal of cardiac hypertrophy in spontaneously hypertensive rats.

  1979cited by this paper
• Effects of cardiac hypertrophy secondary to hypertension on the coronary circulation.

  1979cited by this paper
• Correlation between myocardial structure and diastolic properties of the heart in chronic aortic valve disease: effects of corrective surgery.

  1978cited by this paper
• Ultrastructure of coronary arteries and myocardium in experimental hypertension.

  1978cited by this paper
• Collagen in the normal and hypertrophied human ventricle.

  1977cited by this paper
• Collagen metabolism in experimental cardiac hypertrophy in the rat and the effect of digitoxin treatment.

  1977cited by this paper
• Cardiac Performance in Rats with Renal Hypertension

  1976cited by this paper
• Consequences of intramyocardial arterial lesions in aortic valvular stenosis.

  1976cited by this paper
• Effect of angiotensin-induced hypertension on rat coronary arteries and myocardium.

  1976cited by this paper
• The cellular pathology of experimental hypertension. 7. Structure and permeability of the mesenteric vasculature in angiotensin-induced hypertension.

  1973cited by this paper
• Biochemical Correlates of Cardiac Hypertrophy: V. LABELING OF COLLAGEN, MYOSIN, AND NUCLEAR DNA DURING EXPERIMENTAL MYOCARDIAL HYPERTROPHY IN THE RAT

  1972cited by this paper
• Protocollagen Proline Hydroxylase Activity in Rat Heart During Experimental Cardiac Hypertrophy

  1972cited by this paper
• Biochemical correlates of cardiac hypertrophy. IV. Observations on the cellular organization of growth during myocardial hypertrophy in the rat.

  1969cited by this paper
• The growth of the muscular and collagenous parts of the rat heart in various forms of cardiomegaly

  1969cited by this paper
• The cellular pathology of experimental hypertension. IV. Evidence for increased vascular permeability.

  1969cited by this paper
• Myocardial DNA synthesis in experimental cardiac hypertrophy.

  1968cited by this paper
• ACUTE HYPERTENSIVE VASCULAR DISEASE. 2. STUDIES ON VASCULAR REACTION PATTERNS AND PERMEABILITY CHANGES BY MEANS OF VITAL MICROSCOPY AND COLLOIDAL TRACER TECHNIQUE.

  1964cited by this paper
• ACUTE HYPERTENSIVE VASCULAR DISEASE. 1. RELATION BETWEEN BLOOD PRESSURE CHANGES AND VASCULAR LESIONS IN DIFFERENT FORMS OF ACUTE HYPERTENSION.

  1964cited by this paper

• Impact of temperature and dietary replacement of fishmeal on cardiovascular remodelling and growth performance of adult Atlantic salmon (Salmo salar L.)

  2023cites this paper
• Macro- and micromechanical remodelling in the fish atrium is associated with regulation of collagen 1 alpha 3 chain expression

  2018cites this paper
• Temperature-induced cardiac remodelling in fish

  2017cites this paper
• Inflammation and Heart Failure

  2017cites this paper
• Role of angiotensin-converting enzyme inhibitors in vascular modulation: beyond the hypertensive effects.

  2010cites this paper
• Peptides vasoactifs endogènes dans la prolifération accrue des cellules musculaires lisses vasculaires de rats spontanément hypertendus: rôle des facteurs de croissance

  2009cites this paper
• A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury

  2005cites this paper
• Enzyme Inhibitors in Cardiac and Vascular Protection

  2005cites this paper
• Left Ventricular Failure and Survival in the Cardiomyopathic Hamster

  2005cites this paper
• Nipradilol, a new β-adrenergic blocker, reduces left ventricular remodeling following myocardial infarction in spontaneously hypertensive rats

  2005cites this paper
• The cellular basis of angiotensin converting enzyme mRNA expression in rat heart

  2004cites this paper
• Tonin in rat heart with experimental hypertrophy.

  2003cites this paper
• Effects of angiotensin II type 1 receptor antagonist, YM358, on cardiac hypertrophy and dysfunction after myocardial infarction in rats.

  2002cites this paper
• INCREASED EXPRESSION OF BIGLYCAN mRNA IN PRESSURE-OVERLOADED RAT HEART

  2001cites this paper
• In‐hospital heart failure, first‐year ventricular dilatation and 10‐year survival after acute myocardial infarction

  2001cites this paper
• Regression of myocardial fibrosis in hypertensive heart disease: diverse effects of various antihypertensive drugs.

  2000cites this paper
• Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure.

  1999cites this paper
• Correlation between changes in morphology, electrical properties, and angiotensin-converting enzyme activity in the failing heart.

  1999cites this paper
• Prolonged Captopril Therapy in Murine Viral Myocarditis

  1998cites this paper
• Effect of chronic blockade of angiotensin II-receptor subtypes on aortic compliance in rats with myocardial infarction.

  1998cites this paper
• Molecular Mechanism of Cardiovascular Remodeling

  1998cites this paper
• Electrophysiologic and morphologic abnormalities in the failing heart: effect of enalapril on the electrical properties.

  1997cites this paper
• Inhibitors of the renin‐angiotensin system

  1997cites this paper
• Regression of Chronic Hypoxia-Induced Pulmonary Hypertension, Right Ventricular Hypertrophy, and Fibrosis: Effect of Enalapril

  1997cites this paper
• Angiotensin converting enzyme inhibitor–calcium antagonist combination: an alliance for cardioprotection?

  1997cites this paper
• Nipradilol, a new beta-adrenergic blocker, reduces left ventricular remodeling following myocardial infarction in spontaneously hypertensive rats.

  1997cites this paper
• Weight reduction regresses left ventricular mass regardless of blood pressure level in obese subjects.

  1996cites this paper
• ACE inhibitors before or after heart failure?

  1996cites this paper
• Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease

  1996cites this paper
• Effects of enalapril on T and B cell function in rats after myocardial infarction.

  1995cites this paper
• Ambulatory Blood Pressure and Left Ventricular Changes During Antihypertensive Treatment: Perindopril Versus Isradipine

  1995cites this paper
• Defining the susceptible period of developmental toxicity for the AT1-selective angiotensin II receptor antagonist losartan in rats.

  1995cites this paper
• Treatment of hypertension and concomitant disease in the elderly

  1994cites this paper
• Cellular Mechanisms of Captopril‐Induced Matrix Remodeling in Syrian Hamster Cardiomyopathy

  1994cites this paper
• Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.

  1994cites this paper
• Relative Effects of α1‐Adrenoceptor Blockade, Converting Enzyme Inhibitor Therapy, and Angiotensin II Subtype 1 Receptor Blockade on Ventricular Remodeling in the Dog

  1994cites this paper
• Role of ACE inhibitors in hypertension with left ventricular hypertrophy.

  1994cites this paper
• Angiotensin-converting enzyme inhibition and beta-adrenoceptor blockade regress established ventricular remodeling in a canine model of discrete myocardial damage.

  1994cites this paper
• Regression of hypertensive myocardial hypertrophy does not affect ultrasonic myocardial reflectivity: a tissue characterization study

  1994cites this paper
• Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling.

  1994cites this paper
• Abnormalities in Cardiac Relaxation and Other Forms of Diastolic Dysfunction

  1994cites this paper
• The Role of the Renin-Angiotensin System in Cardiovascular Disease

  1994cites this paper
• Ventrikuläres Remodeling nach Myokardinfarkt. Experimentelle und klinische Untersuchungen

  1993cites this paper
• Neurohumoral activation in preclinical heart failure. Remodeling and the potential for intervention.

  1993cites this paper
• Theoretical basis for the use of angiotensin II antagonists in the treatment of heart failure.

  1993cites this paper
• The transition from experimental to clinical pharmacology: the renin-angiotensin paradigm.

  1993cites this paper
• The renin-angiotensin paradigm. Practical therapeutical consequences of basic research.

  1993cites this paper
• Long-term oral nitrate therapy prevents chronic ventricular remodeling in the dog.

  1993cites this paper
• [Ramipril in the treatment of hypertension. The pharmacodynamic validation of its efficacy in the therapy of initial cardiac and renal involvement].

  1993cites this paper
• Tissue renin-angiotensin systems. Their role in cardiovascular disease.

  1993cites this paper
• Dosing of ACE inhibitors in postinfarct protection

  1993cites this paper
• Identification of Functional Angiotensin II Receptors on Rat Cardiac Fibroblasts

  1993cites this paper
• Ventricular remodeling after myocardial infarction. Experimental and clinical studies.

  1993cites this paper
• Effects of angiotensin-converting enzyme inhibitors on tissue renin-angiotensin systems.

  1992cites this paper
• [Prevention with angiotensin-converting enzyme (ACE) inhibitors].

  1992cites this paper
• Myocardial fibrosis and the concepts of cardioprotection and cardioreparation

  1992cites this paper
• Long‐Term Treatment with Trandolapril Opposes Cardiac Remodeling and Prolongs Survival After Myocardial Infarction in Rats

  1992cites this paper
• Myocardial fibrosis and the renin-angiotensin-aldosterone system.

  1992cites this paper
• Left ventricular remodeling after myocardial infarction: does the cardiac renin-angiotensin system play a role?

  1992cites this paper
• Cardiac myocyte necrosis induced by angiotensin II.

  1991cites this paper
• Myocardial fibrosis: role of ventricular systolic pressure, arterial hypertension, and circulating hormones.

  1991cites this paper
• The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence.

  1991cites this paper
• Signals for the remodeling of the cardiac interstitium in systemic hypertension.

  1991cites this paper
• Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster. Hemodynamic, morphological, and biochemical correlates.

  1991cites this paper
• Influence of angiotensin converting enzyme inhibition on pump function and cardiac contractility in patients with chronic congestive heart failure.

  1991cites this paper
• Enalapril Prevents Cardiac Fibrosis and Arrhythmias in Hypertensive Rats

  1991cites this paper
• Cardioreparative Effects of Lisinopril in Rats With Genetic Hypertension and Left Ventricular Hypertrophy

  1991cites this paper
• Cardiac remodelling and myocardial contractility in patients with congestive heart failure treated with furosemide and enalapril.

  1991cites this paper
• ACE inhibitors and tissue binding.

  1990cites this paper
• Structural Basis of Left Ventricular Dysfunction: Role of Collagen Network Remodeling and Potential Therapeutic Interventions

  1990cites this paper
• Reactive and reparative fibrillar collagen remodelling in the hypertrophied rat left ventricle: two experimental models of myocardial fibrosis.

  1990cites this paper
• Remodeling of the rat right and left ventricles in experimental hypertension.

  1990cites this paper
• Curvature analysis of ventriculograms: how useful is it to assess progression of left ventricular remodeling and dysfunction

  1990cites this paper